Squawk on the Street cover image

Cramer’s Morning Take: Eli Lilly 11/24/25

Squawk on the Street

00:00

Novo Nordisk Alzheimer's Trial Disappoints

Jim Cramer introduces disappointing two-year GLP-1 Alzheimer’s trial results from Novo Nordisk and market reaction.

Play episode from 01:02
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app